These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28144704)

  • 1. Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.
    Ayyala RS; Teot LA; Perez Rossello JM
    Pediatr Radiol; 2017 Apr; 47(4):484-487. PubMed ID: 28144704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging.
    Ayyala RS; Anupindi SA; Callahan MJ
    Abdom Radiol (NY); 2017 Feb; 42(2):502-520. PubMed ID: 27680015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MDP Bone Scintigraphy in Gaucher Disease.
    Kesim S; Turoglu HT; Tutar E; Ozguven S; Erdil TY
    Clin Nucl Med; 2020 Oct; 45(10):e455-e456. PubMed ID: 32604108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle.
    Cho ES; Yu JS; Park AY; Woo S; Kim JH; Chung JJ
    AJR Am J Roentgenol; 2015 Jan; 204(1):69-75. PubMed ID: 25539239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C; Alexander Grant L; Goh V; Griffin N
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.
    Ayyala RS; Anupindi SA; Gee MS; Trout AT; Callahan MJ
    Pediatr Radiol; 2019 Sep; 49(10):1256-1268. PubMed ID: 31350632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of primary pediatric liver tumors.
    Pugmire BS; Towbin AJ
    Pediatr Radiol; 2016 May; 46(6):764-77. PubMed ID: 27229495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primovist, Eovist: what to expect?
    Van Beers BE; Pastor CM; Hussain HK
    J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Liver and Spleen in Children With Gaucher Disease Type 1 With Chemical Shift Imaging.
    Abdel Razek AAK; Barakat T; Ali K
    J Comput Assist Tomogr; 2019; 43(2):183-186. PubMed ID: 30407244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
    Bashir MR; Husarik DB; Ziemlewicz TJ; Gupta RT; Boll DT; Merkle EM
    J Magn Reson Imaging; 2012 Mar; 35(3):611-6. PubMed ID: 22034383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.
    Regenboog M; Bohte AE; Akkerman EM; Stoker J; Hollak CEM
    Br J Haematol; 2017 Nov; 179(4):635-647. PubMed ID: 28905365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.
    Marin D; Catalano C; Rossi M; Guerrisi A; Di Martino M; Berloco P; Passariello R
    J Magn Reson Imaging; 2008 Sep; 28(3):755-8. PubMed ID: 18777536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications.
    Lee NK; Kim S; Lee JW; Lee SH; Kang DH; Kim GH; Seo HI
    Radiographics; 2009 Oct; 29(6):1707-24. PubMed ID: 19959517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
    Park YS; Lee CH; Kim JW; Shin S; Park CM
    World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil.
    Mota RM; Mankin H
    J Pediatr Orthop; 2007; 27(3):347-50. PubMed ID: 17414023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.